Vimarsana
Biggest News Aggregation in the World

Page 15 - Code Therapeutics News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Code Therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Code Therapeutics Today - Breaking & Trending Today

Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session - Vimarsana News

Why Levi Strauss Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

Gainers Liquid Media Group Ltd. (NASDAQ:YVR) jumped 88.1% to $0.2719. Clean Energy Technologies, Inc. (NASDAQ:CETY) surged 47% to $3.44. Clean E...

TransCode Therapeutics Receives Notice of Award from National Institutes of Health (NIH) for Third Year of Grant to Support Clinical Evaluation of TTX-MC138 - Vimarsana News

TransCode Therapeutics Receives Notice of Award from National Institutes of Health (NIH) for Third Year of Grant to Support Clinical Evaluation of TTX-MC138

BOSTON, April 05, 2023 -- TransCode Therapeutics, Inc. , the RNA Oncology Company™ committed to more effectively treating cancer using RNA therapeutics, today announced that it has been... | April 5, 2023

TransCode Therapeutics Reports 2022 Results; Provides Business Update - Vimarsana News

TransCode Therapeutics Reports 2022 Results; Provides Business Update

BOSTON, March 31, 2023 -- TransCode Therapeutics, Inc. , the RNA oncology company committed to defeating cancer using RNA therapeutics, today reported financial results for 2022 and recent business... | March 31, 2023

TransCode Therapeutics : Shareholder Director Nominations - Form 8-K - Vimarsana News

TransCode Therapeutics : Shareholder Director Nominations - Form 8-K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT ... | March 31, 2023

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Down 51.3% in March - Vimarsana News

TransCode Therapeutics, Inc. (NASDAQ:RNAZ) Short Interest Down 51.3% in March

TransCode Therapeutics, Inc. (NASDAQ:RNAZ – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 263,500 shares, a decrease of 51.3% from the February 28th total of 541,400 shares. Currently, 2.3% of the company’s stock are short sold. Based on an average […]